摘要
目的:探讨中西医结合疗法治疗老年晚期非小细胞肺癌(NSCLC)的临床效果及安全性。方法:选择2015年5月至2016年10月期间我院收治的100例老年晚期非小细胞肺癌患者作为研究对象,采用随机数字表法分为单纯化疗组和中西医结合组,疗程结束后对比两组患者的近期疗效、1年生存率、平均生存期及药物不良反应发生情况。结果:中西医结合组患者的治疗总有效率与单纯化疗组比较,差异无统计学意义(P>0.05);中西医结合组患者平均生存期和1年生存率均高于单纯化疗组,组间差异有统计学意义(P<0.05);中西医结合组患者的不良反应生存率显著低于单纯化疗组,组间差异有统计学意义(P<0.05)。结论:相比于单纯化疗治疗,中西医结合治疗老年晚期非小细胞肺癌的临床效果更佳,有助于提高肿瘤控制率,延长患者的生存期,改善患者的生存质量。
Objective: To explore the clinical effect and safety of traditional Chinese and Western medicine therapy on elderly patients with advanced non small cell lung cancer.Methods: during May 2015 to October 2016 in our hospital 100 cases of elderly patients with advanced non-small cell lung cancer patients as the research object, randomly divided into chemotherapy group and Western medicine group, the incidence of curative effect of two groups were compared and the 1 year survival rate, mean survival time and adverse reaction after treatment after. Results: the combination of traditional Chinese and Western medicine group the total efficiency compared with the chemotherapy group, the difference was not statistically significant(P>0.05); group median survival and 1 year survival rate was higher than the chemotherapy group with combination of TCM and Western medicine, there was significant difference between the groups(P<0.05); adverse reaction group of patients survival rate was significantly lower than that of the chemotherapy group with combination of TCM and Western medicine, there was significant difference between the groups(P<0.05). Conclusion: compared to chemotherapy, better clinical effect in the treatment of advanced non-small cell lung cancer with combination of TCM and Western medicine, help to improve tumor control rate, prolong the survival time of patients, improve the patient’s quality of life.
出处
《中国妇幼健康研究》
2017年第S1期139-140,共2页
Chinese Journal of Woman and Child Health Research
关键词
中西医结合
化疗
中医药疗法
晚期非小细胞肺癌
老年患者
生活质量
Traditional Chinese and Western medicine
Chemotherapy
Traditional Chinese medicine therapy
Advanced non-small cell lung cancer
Elderly patients
quality of life
